Eurolyser Diagnostics - Premium Laboratory Equipment

LDL: A new point-of-care test for medical diagnostics

Tuesday, 24. May 2016

Eurolyser enlarges its medical diagnostics product range with a new test for
CUBE-S point-of-care instruments: LDL Cholesterol

The parameter

Low Density Lipoproteins (LDL) are synthesized in the liver by the action of various lipolytic enzymes on triglyceride-rich very low density lipoproteins (VLDL). Specific LDL receptors exist to facilitate the elimination of LDL from plasma by liver parenchymal cells.
 

Why measure LDL Cholesterol?

It has been shown that most of the cholesterol stored in atherosclerotic plaques originates from LDL. It is for this reason that the LDL Cholesterol concentration is considered to be the most important clinical predictor of all single parameters, with respect to coronary atherosclerosis.
 

Applications in diagnostics

Considering the applications discussed above, the Eurolyser LDL Cholesterol assay is anticipated to be of particular interest for cardiologist or general physicians, who want to facilitate their day-to-day operations, receiving results in minutes.
 

Method

Modified polyvinyl sulfonic acid (PVS) and polyethylene-glycol methyl ether (PGME) coupled classic precipitation method.
 

Measurement range/Sensitivity

Range: 0 – 300 mg/dl (LOT dependent)
LOQ:   10 mg/dl
 

More information

For more information click here to go to the LDL Cholesterol test site.

Eurolyser News

9. June 2017

New accessory for CUBE and CUBE-S: SEIKO Label Printer SLP 650SE...
» Read more...

31. May 2017

A new feature for the EOS system: Exporting of measurement results for doctors...
» Read more...

2. December 2016

Importance of a haematocrit (HCT) corrected CRP value...
» Read more...

21. November 2016

K+ Potassium: A new point-of-care test for medical diagnostics...
» Read more...